Hu J - Search Results

1

Uniform and disperse selenium nanoparticles stabilized by inulin fructans from Codonopsis pilosula and their anti-hepatoma activities.

Hu N, Gao Z, Cao P, Song H, Hu J, Qiu Z, Chang C, Zheng G, Shan X, Meng Y. Hu N, et al. Among authors: hu j. Int J Biol Macromol. 2022 Apr 1;203:105-115. doi: 10.1016/j.ijbiomac.2022.01.140. Epub 2022 Jan 29. Int J Biol Macromol. 2022. PMID: 35092739

2

Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice.

Hu J, Che L, Li L, Pilo MG, Cigliano A, Ribback S, Li X, Latte G, Mela M, Evert M, Dombrowski F, Zheng G, Chen X, Calvisi DF. Hu J, et al. Sci Rep. 2016 Feb 9;6:20484. doi: 10.1038/srep20484. Sci Rep. 2016. PMID: 26857837 Free PMC article.

3

Antiproliferative effect of urolithin A, the ellagic acid-derived colonic metabolite, on hepatocellular carcinoma HepG2.2.15 cells by targeting Lin28a/let-7a axis.

Qiu Z, Zhou J, Zhang C, Cheng Y, Hu J, Zheng G. Qiu Z, et al. Among authors: hu j. Braz J Med Biol Res. 2018;51(7):e7220. doi: 10.1590/1414-431x20187220. Epub 2018 May 7. Braz J Med Biol Res. 2018. PMID: 29742265 Free PMC article.

4

Celecoxib alleviates AKT/c-Met-triggered rapid hepatocarcinogenesis by suppressing a novel COX-2/AKT/FASN cascade.

Qiu Z, Zhang C, Zhou J, Hu J, Sheng L, Li X, Chen L, Li X, Deng X, Zheng G. Qiu Z, et al. Among authors: hu j. Mol Carcinog. 2019 Jan;58(1):31-41. doi: 10.1002/mc.22904. Epub 2018 Sep 20. Mol Carcinog. 2019. PMID: 30182439

5

MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway.

Zhang T, Hu J, Wang X, Zhao X, Li Z, Niu J, Steer CJ, Zheng G, Song G. Zhang T, et al. Among authors: hu j. J Hepatol. 2019 Jan;70(1):87-96. doi: 10.1016/j.jhep.2018.08.026. Epub 2018 Sep 13. J Hepatol. 2019. PMID: 30218679 Free PMC article.

6

Metformin delays AKT/c-Met-driven hepatocarcinogenesis by regulating signaling pathways for de novo lipogenesis and ATP generation.

Zhang C, Hu J, Sheng L, Yuan M, Wu Y, Chen L, Zheng G, Qiu Z. Zhang C, et al. Among authors: hu j. Toxicol Appl Pharmacol. 2019 Feb 15;365:51-60. doi: 10.1016/j.taap.2019.01.004. Epub 2019 Jan 6. Toxicol Appl Pharmacol. 2019. PMID: 30625338

7

The preparation, characterization of Lupeol PEGylated liposome and its functional evaluation in vitro as well as pharmacokinetics in rats.

Zhang J, Liang H, Yao H, Qiu Z, Chen X, Hu X, Hu J, Zheng G. Zhang J, et al. Among authors: hu x, hu j. Drug Dev Ind Pharm. 2019 Jul;45(7):1052-1060. doi: 10.1080/03639045.2019.1569038. Epub 2019 Apr 21. Drug Dev Ind Pharm. 2019. PMID: 30939950

8

Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway.

Zhang C , Hu J , Sheng L , Yuan M , Wu Y , Chen L , Wang G , Qiu Z . Zhang C , et al. Among authors: hu j. Food Funct. 2019 Jun 19;10(6):3410-3420. doi: 10.1039/c9fo00284g. Food Funct. 2019. PMID: 31123744

9

Osthole delays hepatocarcinogenesis in mice by suppressing AKT/FASN axis and ERK phosphorylation.

Mo Y, Wu Y, Li X, Rao H, Tian X, Wu D, Qiu Z, Zheng G, Hu J. Mo Y, et al. Among authors: hu j. Eur J Pharmacol. 2020 Jan 15;867:172788. doi: 10.1016/j.ejphar.2019.172788. Epub 2019 Nov 8. Eur J Pharmacol. 2020. PMID: 31712058

10

Celastrol-Loaded Galactosylated Liposomes Effectively Inhibit AKT/c-Met-Triggered Rapid Hepatocarcinogenesis in Mice.

Chen X, Hu X, Hu J, Qiu Z, Yuan M, Zheng G. Chen X, et al. Among authors: hu x, hu j. Mol Pharm. 2020 Mar 2;17(3):738-747. doi: 10.1021/acs.molpharmaceut.9b00428. Epub 2020 Feb 3. Mol Pharm. 2020. PMID: 31904241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,727 results

Search Page

Filters